BlackRock Health Sciences Term Trust (BMEZ) To Go Ex-Dividend on September 15th

BlackRock Health Sciences Term Trust (NYSE:BMEZ) announced a monthly dividend on Friday, June 5th. Shareholders of record on Tuesday, September 15th will be given a dividend of 0.11 per share on Wednesday, September 30th. This represents a c) dividend on an annualized basis and a yield of 8.0%. The ex-dividend date is Tuesday, September 15th.

BlackRock Health Sciences Term Trust Stock Performance

BlackRock Health Sciences Term Trust stock opened at $16.47 on Friday. The stock’s 50-day moving average is $16.07 and its 200-day moving average is $15.00. BlackRock Health Sciences Term Trust has a 12 month low of $13.70 and a 12 month high of $17.25.

Institutional Trading of BlackRock Health Sciences Term Trust

A number of institutional investors and hedge funds have recently bought and sold shares of BMEZ. Baird Financial Group Inc. acquired a new position in BlackRock Health Sciences Term Trust during the first quarter valued at approximately $189,000. Geneos Wealth Management Inc. acquired a new stake in shares of BlackRock Health Sciences Term Trust in the first quarter worth $40,000. NewEdge Advisors LLC increased its position in shares of BlackRock Health Sciences Term Trust by 134.3% in the second quarter. NewEdge Advisors LLC now owns 48,300 shares of the company’s stock worth $689,000 after acquiring an additional 27,686 shares in the last quarter. Jane Street Group LLC raised its stake in shares of BlackRock Health Sciences Term Trust by 157.1% in the 2nd quarter. Jane Street Group LLC now owns 97,472 shares of the company’s stock valued at $1,390,000 after acquiring an additional 59,559 shares during the period. Finally, Ameriprise Financial Inc. raised its stake in shares of BlackRock Health Sciences Term Trust by 14.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 14,521 shares of the company’s stock valued at $212,000 after acquiring an additional 1,787 shares during the period.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.